Keywords: gw, relenza, may, cost, nhs, l115, million

GW's Relenza may cost NHS L115 million

Article | 16 September 1999

Print This

Glaxo Wellcome's Relenza (zanamivir) has sparked controversy inthe UK following reports that a flu epidemic could cost the National Health ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in